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Abstract
Purpose Despite the burgeoning geriatric population with cancer and the importance of understanding how age may be 
related to mental adjustment and quality of life so far, differences in coping strategies and psychological harm between the 
elderly and adults are hardly being taken into account to modify the approach to this population. The aim of this prospective 
study is to describe the differences in psychological characteristics between older and adult cancer patients and examine 
dissimilarities in their psychological evolution during adjuvant chemotherapy.
Methods Adults (18–69 years old) and older patients (≥ 70) with newly diagnosed non-metastatic resected cancer admitted 
to receive adjuvant chemotherapy were recruited. Patients completed the following questionnaires: mini-mental adjustment 
to cancer, brief symptom inventory, shared decision-making questionnaire–patient’s version, multidimensional scale of 
perceived social support, EORTC quality-of-life instrument, life orientation test-revised, and satisfaction with life scale.
Results 500 cancer patients (394 adults and 106 older) were evaluated. The impact of the diagnosis was less negative among 
older patients, with no differences in coping strategies, quality of life, or search for support. Regarding psychological changes 
from the beginning to the end of the adjuvant treatment, both age groups reported more somatic symptoms, increased 
psychological difficulty, reduced coping strategies, and a significant decrease in quality of life at the end of postoperative 
chemotherapy.
Conclusion Although there were clear psychological differences between adults and senior cancer patients, their evolution 
during adjuvant chemotherapy was similar, with deterioration in quality of life and coping. This negative psychological 
impact of adjuvant chemotherapy should be taken into account when considering interventions.
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Introduction
The diagnosis of cancer usually arrives abruptly causing 
psychological distress in almost all patients, with feelings 
of uncertainty, hopelessness, vulnerability, fear, anxiety, 
and sadness. The patient is forced to assume a new iden-
tity as a cancer patient, originating changes in the labor, 
economic, and psychosocial spheres. All this requires a 
major adjustment effort, besides adaptation will influence 
the outcome of the disease [1].
In early stage cancer, adjuvant treatment has improved 
in recent years to reduce recurrence and mortality [2]. 
Hence, issues concerning quality of life (QoL) during and 
after cancer treatment have become increasingly impor-
tant. Good supportive care, including the biopsychosocial 
setting, and the backing of families, is critical to overcome 
cancer and cope with chemotherapy.
Furthermore, cancer is a significant health issue in 
older persons. It is estimated that 43% of all new cases and 
more than 60% of cancer mortality will occur in persons 
aged ≥ 70 years [3]. Moreover, senior cancer patients tend 
to receive less aggressive treatment, due to the fear of an 
increased risk of treatment-related complications [4–9]. 
The development of comorbidities and the accelerated loss 
of autonomy can make older adults with cancer more vul-
nerable [6, 10, 11]. On one hand, age influences the vital, 
physical, mental, and family situation of patients, affecting 
their adaptation to the disease. On the other hand, recent 
studies suggest that age may serve as a protective factor; for 
instance, older people are more prone to emotional repres-
sion [8], stoicism, acceptance of death, greater religious cop-
ing, and adjustment based on passive resignation [9].
Despite the burgeoning geriatric population with cancer 
and the importance of understanding how age may be related 
to mental adjustment and QoL so far, differences in clinical 
course, coping strategies, and psychological harm between 
older and adults are hardly being taken into account to mod-
ify the approach to this population. In this background, the 
aim of this study is to ascertain the differences in clinicopsy-
chological characteristics between older and adult patients 
treated with adjuvant chemotherapy after surgical resection 
of a cancer. We also examine distinctiveness in their psycho-
logical evolution during chemotherapy treatment.
Materials and methods
Design and patients
A prospective, cross-sectional, multi-center study (NEO-
coping) was conducted from July 2015 to July 2017 in 
15 medical oncology departments in different hospitals 
throughout Spain.
Eligible patients were ≥ 18 years who had undergone 
surgery on their cancer in the month prior to the start of 
adjuvant chemotherapy. Old patients were considered those 
aged ≥ 70 years. Patients with dementia or any other serious 
mental illness that prevented survey comprehension were 
excluded. The study was approved by the Ethics Review 
Board at each institution and by the Spanish agency of medi-
cines and medical devices (AEMPS). The study was based 
on the completion of various questionnaires and data collec-
tion procedures were similar for all hospitals. Participation 
was voluntary, anonymous, and would not affect patient care.
Variables
Data on demographic and clinical characteristics (age; gen-
der, marital status; education level; occupational sector; 
tumor site and stage; and time since diagnosis) were col-
lected for statistical purposes through a web-based platform 
(www.neoco ping.es).
Mini-mental adjustment to cancer (M-MAC) is a short 
and refinement version of the original MAC [10] scale, 
one of the most widely used instruments to measure cop-
ing responses in individuals with cancer. M-MAC con-
tains 29 items grouped into five coping strategies: help-
lessness–hopelessness, anxious preoccupation, cognitive 
avoidance, fatalism, and fighting spirit. Anagnostopoulos 
et al. proposed two second-order factors: ‘adaptive’ (fight-
ing spirit, cognitive avoidance, and fatalism subscales) and 
‘maladaptive’ coping (helplessness–hopelessness and anx-
ious preoccupation subscales) [11]. The test–retest reliability 
ranged from 0.62 to 0.99. Cronbach’s alpha ranged from 
0.78 to 0.93 [10].
Brief symptom inventory (BSI)-18 includes 18-item 
divided into three dimensions (somatizations, depression, 
and anxiety) [12]. The somatization dimensions (six items) 
assess: discomfort produced by the perception of corporal 
disorders including cardiovascular, stomach, and muscular 
problems; depression dimension (six items) assess: symp-
toms commonly related to depression, such as apathy, sad-
ness, and thoughts of suicide; and anxiety dimension (six 
items) assess: feelings of fear, general nervousness, and 
even panic. Global symptom index (GSI) summarizes the 
respondent’s overall emotional adjustment or psychological 
distress. Respondents were asked to answer in relation with 
how they had felt the last 7 days, and each item was rated 
on a 5-point Likert scale from 0 (not at all) to 4 (extremely). 
The test–retest reliability ranged from 0.78 to 0.90. Internal 
consistency (Cronbach’s alpha) ranged from 0.81 to 0.90 
[12].
Shared decision-making questionnaire–patient’s ver-
sion (SDM-Q-9) contains 9-item and evaluates the SDM 
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process from the patient’s perspective [13], and are scored 
on a 6-point Likert scale ranging from 0 (completely disa-
gree) to 5 (completely agree). It was adapted and validated 
to Spanish by De las Cuevas et al. [24]. A total raw score of 
between 0 (lowest level of SDM) and 45 is possible. SDM-
Q-9 reveals a high Cronbach alpha in German (0.98), US 
(0.94), and Spanish samples (0.88) of patients with chronic 
diseases.
Multidimensional scale of perceived social support 
(MSPSS) includes 12-item related to three sources of 
social support: family, friends, and significant other [14]. 
Responses are provided using scales that range from 1 
(strongly disagree) to 7 (strongly agree).
European Organization for Research and Treatment of 
Cancer QoL questionnaire instrument (EORTC QLQ-C30) 
is based on 30 individual items summarized in five function-
ing scales: physical functioning, role functioning, emotional 
functioning, social functioning, and cognitive functioning 
and nine symptom scales, e.g., pain, dyspnea, sleep distur-
bance, appetite loss, and diarrhea [15, 16]. The patient is 
requested to rank each of the items on a scale ranging from 
1 (not at all) to 4 (very much).
SDM Questionnaire–Physician’s version (SDM-Q-Doc) 
evaluates the physician’s perspective and how well they fol-
low SDM with their patients [17]. The questionnaire con-
sists of nine items, each of which describes one step of the 
process. The items are scored on a 6-point Likert scale from 
0 (completely disagree) to 5 (completely agree). A total raw 
score of between 0 (lowest level of perceived SDM) and 45 
is calculated by adding the scores of all items. The SDM-Q-
Doc presented good internal consistency and reliability in 
German (α = 0.88) [17].
Life orientation test revised (LOT-R) evaluates optimism 
and pessimism scales, with ten items (three items assess 
optimism, three items assess pessimism, and there are four 
filler items) [18]. Respondents indicated the extent to which 
they agreed with each item on a 5-point Likert scale that 
ranged from 1 (strongly disagree) to 5 (strongly agree). 
Internal consistency varies between 0.74 and 0.78 [18].
Satisfaction with life scale (SWLS) consists of five item 
and was developed as a measure of the judgmental com-
ponent of subjective well-being. Participants indicate how 
much agree or disagree with each of the five items using 
a 7-point scale that ranges from 7 (strongly agree) to 1 
(strongly disagree). The internal consistency (α = 0.86) was 
found to be high [19].
Statistical analyses
Descriptive statistics were used to summarize demographic 
data and survey responses. Absolute frequencies were pre-
sented for categorical data and mean and standard deviation 
(SD) were used for quantitative data. Additional descriptive 
analyses were performed grouping patients by age. The 
bivariate Chi-square and t tests were performed to assess 
the differences between elderly and non-elderly patients in 
some sociodemographic, clinical, and psychological charac-
teristics. Analysis of variance (ANOVA) of repeated meas-
ures was performed taking into account the scores obtained 
before and after chemotherapy adjuvant treatment. The sta-
tistical analyses were run on the IBM-SPSS 23.0 statistical 




The final group consisted of 394 adult patients with cancer 
and 106 older patients. Disease and treatment variables are 
presented in Table 1. The mean age was 54.2 and 74.3 years, 
respectively.
Among adult patients, the percentage of women was 
higher (66 vs 53%, χ2 = 12.196, p < 0.001), they had higher 
level of education (χ2 = 9.142, p < 0.001) and more were 
employed (50 vs 7%, χ2 = 63.187, p < 0.001) than in the 
elderly group. In both groups, the percentage of married or 
living with a partner was similar.
Regarding the type of cancer, non-elderly patients pre-
sented mainly breast cancer (39%) followed by colorectal 
cancer (37%), while the elderly presented mainly colorectal 
cancer (52%) followed by breast cancer in 15%. Most adult 
patients had stage I–II disease (59%), while senior patients 
had predominantly stage III cancer (56%), with significant 
differences in both groups (p = 0.003). The risk of recurrence 
was also higher in cancers of older group [t(498) = − 2.747, 
p = 0.007]. Significant differences were found in adjuvant 
treatment, the therapy of choice in the elderly was mainly 
mono-chemotherapy, whereas in younger patients, it was 
polychemotherapy combined with radiotherapy in 41%. The 
time until diagnosis was slightly higher in non-elderly adults 
than in older adults, although there were no significant dif-
ferences in both groups.
Psychological adaptation to cancer
Differences in psychological adaptation process by cancer 
type and patient’s age is reported in Table 2.
Cancer diagnosis Impact of the cancer diagnosis was 
less negative among older than adult cancer patients 
[t(495) = 2.544, p = 0.001, Cohen’s d = 0.296]. Adult cancer 
patients experienced the diagnosis more negatively, with 
more symptoms of anxiety, depression, and somatization 
than older cancer patients.
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Coping with cancer and QoL Both groups mainly used 
adaptive coping strategies, the two most used were the fight-
ing spirit and fatalism, while hopelessness was the least 
used. There were no significant differences in QoL nor in the 
search for social support, and both groups received support 
mainly from the family and the social environment.
SDM Medical oncologists were more satisfied in SDM 
with adult patients than with the elderly [t(498) = 2.127, 
p = 0.034, Cohen’s d = 0.247]. Patients, meanwhile, feel 
remarkably satisfied with SDM, without significant differ-
ences between age groups.
Psychological change after adjuvant treatment
To study the psychological change produced by cancer treat-
ment, repeated measures ANOVA was performed taking into 
account the scores obtained before and after adjuvant treat-
ment of the cancer applied to 207 of the patients. This reduc-
tion of the sample was due to the fact that only these subjects 
had already finished adjuvant treatment during the course 
of this study. The results for the dimensions of the BSI-
18, Mini-MAC, and EORTC QLQ-C30 scales are shown in 
Table 3 and Fig. 1.
Both age groups reported more somatic symptoms 
[F(1205) = 45.271, p < 0.001, η = 0.181], and greater psy-
chological distress at the end of treatment [F(1205) = 9.046, 
p = 0.003, η = 0.048]. As for the coping strategies, both 
groups reduced the adaptive [F(1205) = 5.961, p = 0.016, 
η = 0.016] and maladaptive strategies [F(1205) = 11.610, 
p = 0.001, η = 0.056]. From adaptive strategies, the fight-
ing spirit and fatalism diminished, and cognitive avoidance 
remained stable and of the maladaptive strategies, both 
groups diminished helplessness–hopelessness and anxious 
preoccupation.
Regarding the QoL, adult and senior patients reported 
a significant decrease in their QoL at the end of the adju-
vant treatment in symptom scale [F(1203) = 14.166, p < 0.001, 
η = 0.065], health status [F(1203) = 5.026, p = 0.026, 
η = 0.025], and in QoL [F(1137) = 9.526, p = 0.002, η = 0.046].
Discussion
In this study, we analyzed psychological resources and 
their evolution through adjuvant chemotherapy in sen-
ior and adult cancer patients. The adult group is formed 
Table 1  Characteristics of adult 
and elderly patients
CT chemotherapy, RT radiotherapy, SD standard deviation









Gender: n (%) 12.196 0.001
 Women 309 (62) 259 (66) 56 (53)
 Men 191 (38) 135 (34) 56 (47)
Age: years, mean (SD) 58.5 (12.2) 54.2 (10) 74.3 (3.5) − 32.784 0.001
Marital status:
 Married/partnered: n (%) 385 (77) 306 (78) 80 (75) 0.277 0.599
 Others 88 (22) 26 (25)
Educational level: n (%)
 Basic 288 (58) 213 (54) 75 (70) 9.142 0.002
 Medium 212 (42) 181 (46) 31 (30)
Unemployed: n (%) 290 (58) 195 (50) 99 (93) 63.187 0.001
Localization of cancer: n (%)
 Colorectal 201 (40) 146 (37) 55 (52) 23.205 0.001
 Breast 170 (34) 154 (39) 16 (15)
 Others 129 (26) 344 (24) 95 (33)
Stage: n (%)
 I–II 277 (55.4) 232 (59) 47 (44) 9.080 0.003
 III 207 (41.4) 150 (38) 59 (56)
Time since diagnosis: days, 
mean (SD)
85.2 (127) 89.1 (130) 71 (113) 1.168 0.243
Type of treatment: n (%)
 CT + surgery 318 (64) 234 (59) 84 (79) 14.233 0.001
 CT + surgery + RT 182 (36) 160 (41) 22 (21)
 Risk of relapse 42.9 (23.2) 41.3 (22.5) 48.7 (24.9) − 2.747 0.007
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mostly by women, with a higher level of education, and 
working. In contrast, patients in the older group tend to be 
men, with a basic level of education and are mostly retired 
(93%). There are several reasons for these differences: 
patients aged ≥ 70 years were born during the Spanish 
civil war (1936–1939) or in the post-war period, which 
implied a precarious economic situation and a less access 
Table 2  Comparison of 
clinical–psychological 
characteristics and scales 
between adult and elderly 
patients
a T score






T p Effect size
Psychological distress scale (BSI-18)a 64.8 (6.7) 62.9 (6.1) 2.544 0.011 0.296
 Anxiety 62.6 (7.7) 60.2 (6.9) 2.870 0.004 0.328
 Depression 61.1 (6.0) 59.7 (5.8) 2.225 0.027 0.237
 Somatization 61.6 (6.9) 60.2 (5.8) 2.140 0.034 0.220
Coping with cancer scale (M-MAC)
 Adaptive 66.5 (16.5) 67.9 (16.3) − 0.769 0.442 –
 Maladaptive 31.5 (19.1) 31.0 (20.6) 0.237 0.813 –
Social support scale (MPSS)
 Familial 25.6 (3.8) 26.1 (2.9) − 1.243 0.215 –
 Friends 23.6 (5.3) 22.6 (5.0) 1.798 0.073 –
 Social 25.8 (3.8) 25.6 (3.8) 1.319 0.188 –
QoL scale (EORTC QLQ-C30)
 Functional scale 40.8 (11.7) 38.4 (12.4) 1.844 0.066 –
 Symptom scale 39.7 (11.9) 38.2 (10.9) 1.180 0.238 –
 Health status 74.1 (17.7) 73.7 (18.9) − 0.227 0.820 –
 QoL 35.5 (11.9) 34.4 (11.8) 0.863 0.388 –
Shared decision-making scale
 Version physician (SDM-doc) 91.2 (9.3) 88.8 (10.1) 2.127 0.034 0.247
 Version patient (SDM-Q-9) 82.1 (19.2) 82.4 (19.2) − 0.143 0.887 –
Table 3  Results of the multivariate analysis of variance repeated measures
Mean (standard deviation)
Pre the scores obtained before adjuvant chemotherapy, Post the scores obtained after adjuvant treatment of the cancer
* p < 0.01
** p < 0.001
Adults cancer Older cancer Total Time × age Age Time
Pre Post Pre Post Pre Post F F F
Psychological dis-
tress scale (BSI)
64.8 (7.1) 66.0 (6.8) 63.6 (5.8) 66.2 (7.4) 64.6 (6.8) 66.0 (6.9) 1.385 0.204 9.046**
 Anxiety 62.0 (7.9) 60.9 (7.0) 59.6 (6.6) 60.6 (8.3) 61.4 (7.7) 60.9 (7.3) 3.706 1.598 0.000
 Depression 61.1 (6.2) 60.8 (6.0) 59.5 (5.8) 60.6 (6.0) 60.7 (6.1) 60.8 (6.0) 1.974 1.250 0.683
 Somatization 61.2 (6.8) 65.9 (7.1) 60.1 (5.6) 63.6 (7.1) 61.0 (6.5) 65.4 (7.1) 0.963 3.368 45.271**
Mental adjustment to cancer (M-MAC)
 Adaptive 65.6 (18.1) 60.7 (18.6) 67.8 (16.1) 65.8 (21.1) 66.1 (17.6) 61.9 (19.3) 1.023 1.772 5.961*
 Maladaptive 33.1 (19.9) 25.6 (19.7) 27.9 (19.5) 25.6 (21.1) 31.9 (19.9) 25.6 (20.0) 3.286 0.721 11.610**
QoL scale (EORTC-QLQ-C30)
 Functional scale 40.3 (11.6) 42.3 (13.9) 39.7 (14.4) 41.7 (14.3) 40.1 (12.3) 42.2 (13.9) 0.004 0.105 3.472
 Symptom scale 39.0 (10.8) 43.2 (13.5) 38.4 (10.1) 42.1 (13.5) 38.9 (10.6) 42.9 (13.5) 0.050 0.271 14.166**
 Health status 24.7 (17.4) 29.9 (21.0) 27.1 (18.9) 30.5 (16.9) 25.2 (17.7) 30.0 (20.1) 0.218 0.303 5.065*
 Quality of life 34.6 (11.5) 38.7 (12.9) 35.7 (12.5) 38.4 (11.9) 34.9 (11.7) 38.6 (12.7) 0.370 0.046 9.526**
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to formal education; regarding the employment rate, the 
average retirement age in our country is 65 years old.
With respect to the type of cancer, adult patients had 
mainly breast cancer followed by colorectal cancer and older 
patients usually had colorectal cancer, followed by breast 
cancer. Although the time to diagnosis did not differ sig-
nificantly between the two groups, most adult patients were 
diagnosed in early stages (stages I and II), with lower risk of 
recurrence, and older patients were mostly in stage III with 
higher risk for relapse. This may reflect the fact that the age 
of population screening for breast cancer in Spain is up to 
69 years and screening for colorectal cancer is not yet fully 
established. In addition, older people take longer to consult 
when they have symptoms and this delays the diagnosis.
Adult patients most frequently received combined multi-
modality treatment. Nevertheless, elderly patients are 
mainly treated with surgery and mono-chemotherapy and 
less radiotherapy. Previous studies indicate that older can-
cer patients are much often undertreated [20, 21]. The main 
reasons at the origin of undertreatment were a higher preva-
lence of co-morbidity, shorter life expectancy, absence of an 
elderly population in clinical trials, and increased adverse 
effects of treatment. However, there are elderly patients 
with good general condition and without comorbidities, so 
adjuvant treatments should be adapted to the older patient’s 
general health status and offer the best chance of cure in 
each case [4–6].
Regarding psychological adjustment to cancer, younger 
patients cope worse with the disease, as they present more 
anxiety, depression, somatic symptoms, and psychological 
distress than older ones. There are several explanations 
for why psychological adjustment increases with age [22, 
23]. This may be because older people are more likely to 
take their lives on the basis of ‘here and now’, to have a 
Fig. 1  Scores obtained in ques-
tionnaires before (pre) and after 
(post) adjuvant chemotherapy: 
Brief Symptom Inventory (BSI-
18), Mini-Mental Adjustment to 
Cancer (M-MAC) and European 
Organization for Research and 
Treatment of Cancer quality-
of-life questionnaire instrument 
(EORTC-QLQ-C30) before and 
after adjuvant treatment applied 
to 207 of the patients
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greater life perspective and more experiences than younger 
people, what some call ‘psychological immunization’ that 
would help them to live cancer from a different vital per-
spective. In addition, young people face a vital situation 
in which other age-related roles take center stage, such 
as caring for work, children, and parents, and that can 
increase stress on cancer [22]. There were no differences 
in the use of adaptive coping strategies between both age 
groups; the two most used were the fighting spirit and 
fatalism, while hopelessness was the least used. This is 
rather similar to the results of the previous research con-
ducted only in older adult by Deimling et al. [24]. In our 
series, older people showed a tendency toward greater 
emotional regulation. QoL data and social support were 
similar and this was received mainly from the family and 
the social environment in both groups.
Even though medical oncologists appear to be more 
comfortable in communicating with younger patients, both 
groups of patients were very satisfied with SDM, showing 
no real barriers depending on age. This situation should 
be more difficult in a different scenario as for example in 
the metastatic setting [25].
Adult patients experienced a more optimistic view 
about cancer and prognosis than older ones. Other authors 
as Deimling et al. have also shown this perspective in can-
cer-related worries in elderly longer survivors [26]. As a 
result, while older patients better accepted the diagnosis 
with less psychological distress, they were more pessimis-
tic about treatment and prognosis.
Concerning psychological change after adjuvant treat-
ment, both age groups reported more somatic symptoms 
and greater psychological distress at the end of adju-
vant chemotherapy, with no differences between the two 
groups. Regarding the coping strategies, both groups 
reduced the adaptive and maladaptive strategies. As for 
QoL, both adult and older patients reported a clinically 
relevant decrease in their QoL after the chemotherapy was 
completed. This is also reflected in previous studies only 
in elderly population by Puts et al. [27] and Fitzpatrick 
et al. [28].
The fundamental limitation of this study is inherent 
in its cross-sectional design, which makes it difficult to 
explore the dynamic nature of the clinical–psychological 
processes and their variability during adjuvant chemother-
apy. Besides, the information after completion of chemo-
therapy could only be obtained in 207 patients.
To conclude, we would like to emphasize that despite 
clear psychological differences between adult and older 
cancer patients, their evolution during adjuvant chemo-
therapy was similar.
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